Jcourse
it has nothing to do with ASX or in US. It is all about risk and reward for mid-cap pharma companies like SRX. If SRX is undervalued, big pharma will do a T/O vice versa.
A lot of holders in ASX might misinterpret the trail results, but certainly not me as I have personally overseas trials in Australia and in UK. The trails results will speak for itself. There is a reason why survival were used a a primary endpoint. People need to accept that not meeting primary endpoint in clinical trial is not something very unusual and perhaps also not the end of the world. Thus, a 12% dropped today is fair and reasonable. SRX still worth about $800-900mil which is why I was only sold 50% of my total holdings. the next 2 trails are extremely important.
DYOR
- Forums
- ASX - By Stock
- SRX
- Sirt result
Sirt result, page-72
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SRX (ASX) to my watchlist
(20min delay)
|
|||||
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $75.62M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
SRX (ASX) Chart |
Day chart unavailable
The Watchlist
BM8
BATTERY AGE MINERALS LTD
Nigel Broomham, CEO
Nigel Broomham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online